Alex Zhavoronkov, PhD (aka Aleksandrs Zavoronkovs)(@biogerontology):Tempus trained a foundation model on 1.67M real cancer patients, fusing clinical trajectories with DNA, RNA, and H&E pathology into one patient-state embedding. Overall-survival AUC jumped 0.563 to 0.774, and treatment-benefit ranking improved in 9 of 11 cohorts. We have argued for years that multimodal models beat curated features in oncology. This is strong evidence at real scale.

Alex Zhavoronkov, PhD (aka Aleksandrs Zavoronkovs)

@biogerontology

My posts are strictly personal, not reflective of positions or policies of Insilico Medicine, which disclaims any responsibility for my individual statements.

Joined February 2010

1.8K Following 44K Followers

Alex Zhavoronkov, PhD (aka Aleksandrs Zavoronkovs)@biogerontology

2026.08.26 14:22

Tempus trained a foundation model on 1.67M real cancer patients, fusing clinical trajectories with DNA, RNA, and H&E pathology into one patient-state embedding. Overall-survival AUC jumped 0.563 to 0.774, and treatment-benefit ranking improved in 9 of 11 cohorts. We have argued for years that multimodal models beat curated features in oncology. This is strong evidence at real scale.